Bio-Rad Laboratories | BIO - Sales Revenues


Bio-Rad Laboratories reported $651M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Abbott USD 12.59B 1.43B Jun/2026
Agilent USD 1.84B 37M Mar/2026
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Bio Techne USD 311.4M 15.5M Mar/2026
Bio-Rad Laboratories USD 651M 58.9M Jun/2026
Bruker USD 838.5M 15.1M Jun/2026
Charles River Laboratories USD 1000M 4.2M Jun/2026
Danaher USD 6.3B 350M Jun/2026
General Electric Aerospace USD 12.63B 1.03B Jun/2026
Illumina USD 1.16B 70M Jun/2026
IQVIA Holdings USD 4.37B 220M Jun/2026
Laboratory Of America USD 3.73B 190M Jun/2026
Merck USD 16.6B 310M Jun/2026
Mettler Toledo International USD 1.03B 82.87M Jun/2026
Myriad Genetics USD 190.7M 9.7M Jun/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Quest Diagnostics USD 3.04B 140M Jun/2026
Repligen USD 204M 10M Jun/2026
Revvity USD 729.68M 18.68M Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Siemens EUR 20.79B 1.03B Jun/2026
Standard Biotools USD 21.1M 2.7M Mar/2026
Thermo Fisher Scientific USD 11.99B 980M Jun/2026
Tosoh JPY 274.17B 10.33B Jun/2026
Waters USD 1.64B 370M Jun/2026